Browsing by Author Weltman, Martin

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 21 to 40 of 43 < previous   next >
Issue DateTitleAuthor(s)Citation
2008Evaluating abnormal liver testsGeorge, Jacob; Segal, Isador; Talley, Nicholas J.; Weltman, Martin; Western Clinical School: Westmead Millennium InstituteEvaluating abnormal liver tests in Gastroenterology and Hepatology: a clinical handbook, Elsevier, 2008, pp. 316-326
2016FibroGENE: A gene-based model for staging liver fibrosisAhlenstiel, Golo; Booth, David; Douglas, Mark; Eslam, Mohammed; George, Jacob; Kelaeng, Kebitsaone; Liddle, Christopher; Weltman, Martin; Abate, Maria; Adams, Leon Anton; Berg, Thomas; Chan, Henry Lik Yuen; Dore, Gregory; et al, Various; Hashem, Ahmed M; Irving, William; Mangia, Alessandra; Romero-Gomez, Manuel; Sheridan, David; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Medicine (Westmead); Nepean Clinical School: MedicineFibroGENE: A gene-based model for staging liver fibrosis, Journal of Hepatology, vol.64, 2, 2016,pp 390-398
2012Hepatitis C treatment outcomes in Australian clinicsGeorge, Jacob; Haber, Paul; Amin, Janaki; Dore, Gregory; Gidding, Heather F.; Law, Matthew; Macdonald, Graeme A; Ostapowicz, George; Sasadeusz, J; Weltman, Martin; Western Clinical School: Westmead Millennium Institute; Central Clinical School: Addiction MedicineHepatitis C treatment outcomes in Australian clinics, Medical Journal of Australia, vol.196, 10, 2012,pp 633-637
2002HFE Mutations, Hepatic Iron, and Fibrosis: Ethnic-Specification Association of NASH with C282Y but not with Fibrotic SeverityFarrell, Geoffrey; George, Jacob; Liddle, Christopher; Lin, Rita; Samarasinghe, Dev; Weltman, Martin; Abeygunasekera, Shehan; Chitturi, Shivakumar; McDonald, David; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Nepean Clinical School: MedicineHFE Mutations, Hepatic Iron, and Fibrosis: Ethnic-Specification Association of NASH with C282Y but not with Fibrotic Severity, Hepatology, vol.36, 1,pp 142-149
2015Identification of early environmental risk factors for irritable bowel syndrome and dyspepsiaWeltman, Martin; Bone, C.; Gowryshankar, Ashwini; Jones, Michael P.; Kalantar, Jamshid S; Koloski, Natasha A.; Talley, Nicholas; Walker, Marjorie M; Nepean Clinical School: MedicineIdentification of early environmental risk factors for irritable bowel syndrome and dyspepsia, Neurogastroenterology and Motility, vol.27, 9, 2015,pp 1317-1325
2011Identification of improved IL28B SNPs and haplotypes for prediction of drug response in treatment of hepatitis C using massively parallel sequencing in a cross-sectional European cohortAhlenstiel, Golo; Booth, David; George, Jacob; O'Connor, Kate; Stewart, Graeme; Suppiah, Vijayaprakash; Weltman, Martin; Abate, Maria; Bahlo, Melanie; Bassendine, Maragaret; Berg, Thomas; Irving, William; Matthews, Gail V; Powell, Elizabeth E.; Riordan, Stephen; Smith, Katherine; Spengler, Ulrich; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Nepean Clinical School: MedicineIdentification of improved IL28B SNPs and haplotypes for prediction of drug response in treatment of hepatitis C using massively parallel sequencing in a cross-sectional European cohort, Genome Medicine: medicine in the post-genomic era, vol.3, 8, 2011,pp 57-1-57-13
2014IFNL3 mediates interaction between innate immune cells: Implications for hepatitis C virus pathogenesisAhlenstiel, Golo; Booth, David; Douglas, Mark; George, Jacob; Leung, Reynold; Liddle, Christopher; O'Connor, Kate; Ong, Adrian; Schibeci, Stephen; Stewart, Graeme; Suppiah, Vijayaprakash; van der Poorten, David; Weltman, Martin; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Medicine; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Children's Hospital Westmead: MedicineIFNL3 mediates interaction between innate immune cells: Implications for hepatitis C virus pathogenesis, Innate Immunity, vol.20, 6, 2014,pp 598-605
2011IL28B, HLA-C, and KIR Variants Additively Predict Response to Therapy in Chronic Hepatitis C Virus Infection in a European Cohort: A Cross-Sectional Study.Ahlenstiel, Golo; Booth, David; George, Jacob; O'Connor, Kate; Stewart, Graeme; Suppiah, Vijayaprakash; Weltman, Martin; Abate, Maria; Armstrong, Nicola; Bassendine, Maragaret; Berg, Thomas; Dore, Gregory J.; et al, various; Gaudieri, Silvana; Hellard, Margaret; Irving, William; Powell, Elizabeth E.; Spengler, Ulrich; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Nepean Clinical School: MedicineIL28B, HLA-C, and KIR Variants Additively Predict Response to Therapy in Chronic Hepatitis C Virus Infection in a European Cohort: A Cross-Sectional Study., PLoS Medicine, vol.8, 9, 2011,pp e1001092-1-e1001092-8
2009Impact of high-dose peginterferon alfa-2A on virological response rates in patients with hepatitis C genotype 1: a randomized controlled trial.McCaughan, Geoffrey; Weltman, Martin; Cheng, Wendy; Crawford, Darrell; DePamphilis, Jean; Desmond, Paul V; Dore, Gregory J.; Marks, Phillipa; Rawlinson, William D.; Rizkalla, Bishoy; Roberts, Stuart; Sievert, William; Yoshihara, Motoko; Central Clinical School: Centenary Institute; Nepean Clinical School: MedicineImpact of high-dose peginterferon alfa-2A on virological response rates in patients with hepatitis C genotype 1: a randomized controlled trial., Hepatology, vol.50, 4,pp 1045-1055
2013Implementing guidelines on the prevention of opportunistic infections in inflammatory bowel diseaseSelby, Warwick; Veillard, Anne-Sophie; Burger, Daniel; Connor, Susan; Grimm, Michael C.; Howlett, M; Lawrance, Ian; Radford-Smith, Graham; Travis, Simon; Vivekanandarajah, S.; Walsh, Alissa; Weltman, Martin; Central Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials CentreImplementing guidelines on the prevention of opportunistic infections in inflammatory bowel disease, Journal of Crohn's and Colitis, vol.7, 10, 2013,pp e449-e456
2015Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver diseaseAhlenstiel, Golo; Booth, David; Douglas, Mark; Eslam, Mohammed; George, Jacob; Leung, Reynold; Liddle, Christopher; Weltman, Martin; Abate, Maria; Adams, Leon A.; Berg, Thomas; Chan, Henry L K; Dore, Gregory; et al, Various; Hashem, Ahmed M; Irving, William; Mangia, Alessandra; Romero-Gomez, Manuel; Sheridan, David; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Nepean Clinical School: MedicineInterferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease, Nature Communications, vol.6, N/A, 2015,pp 1-10
2014Interleukin-28B rs12979860 C allele: Protective against advanced fibrosis in chronic hepatitis C genotype 1 infectionGeorge, Jacob; Leung, Reynold; Button, Peter; Cheng, Wendy; Crawford, Darrell H G; Dore, Gregory J.; Kitson, Matthew; McCaughan, Geoffrey W.; Roberts, Stuart; Sievert, William; Weltman, Martin; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Medicine (Westmead)Interleukin-28B rs12979860 C allele: Protective against advanced fibrosis in chronic hepatitis C genotype 1 infection, Journal of Gastroenterology and Hepatology, vol.29, N/A, 2014,pp 1458-1462
2010Low virological response and high relapse rates in hepatitis C genotype 1 patients with advanced fibrosis despite adequate therapeutic dosingWeltman, Martin; Cheng, Wendy; Crawford, Darrell; Dore, Gregory J.; Marks, Phillipa; McCaughan, Geoffrey W.; Rawlinson, William; Rizkalla, Bishoy; Roberts, Stuart; Sievert, William; Thommes, James; Yoshihara, Motoko; Nepean Clinical School: MedicineLow virological response and high relapse rates in hepatitis C genotype 1 patients with advanced fibrosis despite adequate therapeutic dosing, Journal of Hepatology, vol.53, 4,pp 616-623
2007Modelling the hepatitis C virus epidemic in AustraliaGeorge, Jacob; Weltman, Martin; Bell, Jane; Cooper-Stanbury, Mark; Dolan, Kate; Dore, Gregory J.; et, al; Kaldore, John; Karvelas, Maria; Li, Jiong; Maher, Lisa; Razali, Karina; Thein, Hla Hla; Western Clinical School: Westmead Millennium Institute; Nepean Clinical School: MedicineModelling the hepatitis C virus epidemic in Australia, Drug and Alcohol Dependence, vol.91,(39509),2007,pp 228-235
2006Naltrexone versus acamprosate in the treatment of alcohol dependence: a multi-centre, randomized, double-blind, placebo-controlled trial.Haber, Paul; Weltman, Martin; Bell, James R.; Morley, Kirsten C.; Phung, Nghi; Reid, Sophie C.; Richardson, Kylie; Sannibale, Claudia; Teesson, Maree; Thomson, Clare; Central Clinical School: Addiction Medicine; Nepean Clinical School: MedicineNaltrexone versus acamprosate in the treatment of alcohol dependence: a multi-centre, randomized, double-blind, placebo-controlled trial., Addiction, vol.101,(10),2006,pp 1451-1462
2002NASH and Insulin Resistance: Insulin Hypersecretion and Specific Association with the Insulin Resistance SyndromeChitturi, Shivakumar; Farrell, Geoffrey; George, Jacob; Hui, Jason; Karim, Rooshdiya; Liddle, Christopher; Lin, Rita; Samarasinghe, Dev; Weltman, Martin; Abeygunasekera, Shehan; Fung, Caroline; Holmes-Walker, Jane; Medicine Faculty Office; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Clinical Schools; Concord Clinical School: Medicine; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Nepean Clinical School: MedicineNASH and Insulin Resistance: Insulin Hypersecretion and Specific Association with the Insulin Resistance Syndrome, Hepatology, vol.35,(2),2002,pp 373-379
2004Oropharyngeal scintigraphy: a reliable technique for the quantitative evaluation of oral-pharyngeal swallowingWeltman, Martin; Collins, P. J.; Cook, I. J.; McKay, E; Shaw, D. W.; Simula, M. E.; Smart, R; Wallace, K. L.; Williams, R. B. H.; Nepean Clinical School: MedicineOropharyngeal scintigraphy: a reliable technique for the quantitative evaluation of oral-pharyngeal swallowing, Dysphagia, vol.19,(1),2004,pp 36-42
2011Patients admitted for inpatient cannabis detoxification: withdrawal symptoms and impacts of common comorbiditiesConigrave, Katherine; Dawes, Gareth; Phung, Nghi; Weltman, Martin; Sitharthan, Thiagarajan; Central Clinical School: Addiction Medicine; Western Clinical School: Addiction Medicine; Medicine; Nepean Clinical School: MedicinePatients admitted for inpatient cannabis detoxification: withdrawal symptoms and impacts of common comorbidities, Journal of Substance Use, vol.16, 5, 2011,pp 392-405
2014Relationship between disease severity and quality of life and assessment of health care utilization and cost for ulcerative colitis in Australia: A cross-sectional, observational studySelby, Warwick; Weltman, Martin; Bampton, Peter; Black, Christopher; et al, Various; Gibson, Peter R; Lawrance, Ian; Nicholls, Rebecca; Sparrow, Miles; Vaizey, Carolynne; Weston, Adele; Central Clinical School: Medicine; Nepean Clinical School: MedicineRelationship between disease severity and quality of life and assessment of health care utilization and cost for ulcerative colitis in Australia: A cross-sectional, observational study, Journal of Crohn's and Colitis, vol.8, 7, 2014,pp 598-606
2014Systematic review with meta-analysis: clinical manifestations and management of autoimmune hepatitis in the elderlyEslick, Guy; Chen, J; Weltman, Martin; Nepean Clinical School: SurgerySystematic review with meta-analysis: clinical manifestations and management of autoimmune hepatitis in the elderly, Alimentary Pharmacology and Therapeutics, vol.39, 2, 2014,pp 117-124